FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 296:70-75 January 13, 1977 Number 2 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We evaluated the therapeutic effect of L-5-hydroxytryptophan (L-5HTP), the precursor of serotonin (5-hydroxytryptamine), combined with carbidopa, a peripheral decarboxylase inhibitor, in patients with intention myoclonus and examined the serotonin metabolites in spinal fluid, blood and urine before and during therapy. In 18 patients with intention myoclonus due to anoxia or other brain damage, 11 derived more than 50% overall improvement during treatment with L-5HTP and carbidopa. Spinal-fluid 5-hydroxyindoleacetic acid was 35% lower in patients with intention myoclonus than in controls (P less than 0.05). Therapy with L-5HTP and carbidopa increased the concentration of serotonin metabolites in urine and spinal fluid. We postulate that a deficiency of brain serotonin is causally related to intention myoclonus and that the therapeutic effect of L-5HTP and carbidopa may be due to the repletion of serotonin in regions of the brain where serotoninergic neurons have degenerated.

This article has been cited by other articles:

• Birmaher, B., Kaufman, J., Brent, D. A., Dahl, R. E., Perel, l. M., Al-Shabbout, M., Nelson, B., Stull, S., Rao, U., Waterman, G. S., Williamson, D. E., Ryan, N. D. (1997). Neuroendocrine Response to 5-Hydroxy-L-Tryptophan in Prepubertal Children at High Risk of Major Depressive Disorder. Arch Gen Psychiatry 54: 1113-1119 [Abstract]  
• Pranzatelli, M. R. (1994). Serotonin and Human Myoclonus: Rationale for the Use of Serotonin Receptor Agonists and Antagonists. Arch Neurol 51: 605-617 [Abstract]  
• Ryan, N. D., Birmaher, B., Perel, J. M., Dahl, R. E., Meyer, V., Al-Shabbout, M., Iyengar, S., Puig-Antich, J. (1992). Neuroendocrine Response to L-5-Hydroxytryptophan Challenge in Prepubertal Major Depression: Depressed vs Normal Children. Arch Gen Psychiatry 49: 843-851 [Abstract]  
• Maiese, K., Caronna, J. J. (1988). Coma Following Cardiac Arrest: A Review of the Clinical Features, Management, and Prognosis. J Intensive Care Med 3: 153-163 [Abstract]  
• Garvey, M. J., Tollefson, G. D. (1987). Occurrence of Myoclonus in Patients Treated With Cyclic Antidepressants. Arch Gen Psychiatry 44: 269-272 [Abstract]  
• Sotaniemi, K. (1982). Valproic Acid in the Treatment of Nonepileptic Myoclonus: Report of Three Cases. Arch Neurol 39: 448-449 [Abstract]  
• Menon, M. K. (1981). Antimyoclonic Effect of Sodium Oxybate: Clinical Implications. JAMA 245: 2495-2496 [Abstract]  
• Menon, M. K. (1980). Possible Value of Baclofen in Myoclonus. JAMA 244: 239-240 [Abstract]  
• Cohen, D. J., Shaywitz, B. A., Caparulo, B., Young, J. G., Bowers, M. B. Jr (1978). Chronic, Multiple Tics of Gilles de la Tourette's Disease: CSF Acid Monoamine Metabolites After Probenecid Administration. Arch Gen Psychiatry 35: 245-250 [Abstract]  
• Hanley, H. G., Stahl, S. M., Freedman, D. X. (1977). Hyperserotonemia and Amine Metabolites in Autistic and Retarded Children. Arch Gen Psychiatry 34: 521-531 [Abstract]